Genesis Pharmaceuticals Closes $30 Million Private Note Placement
LAIYANG, China, June 3 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GTEC) (“Genesis” or the “Company”), a leading pharmaceutical company in the People’s Republic of China, today announced that on May 30, 2008, it successfully completed a private placement of an aggregate principal amount of $30,000,000 of its three year convertible notes (the “Notes”). |